Abstract #1 Cushing’s Disease Manifesting as Multiple Pituitary Adenomas With Corticotroph Hyperplasia
نویسندگان
چکیده
1 Cushing’s Disease Manifesting as Multiple Pituitary Adenomas With Corticotroph Hyperplasia Anupam Srivastava, MD, and Romesh K. Khardori, MD, FACE A 51-year-old man presented with chief complaints of proximal muscle weakness and drooping of eyelids. An initial diagnosis of seronegative myasthenia gravis was made, and he was empirically treated with corticosteroids, which made his symptoms worse. Further work-up, which included low-dose and high-dose dexamethasone suppression testing, revealed results suggestive of Cushing’s disease. Magnetic resonance imaging (MRI) of the pituitary gland disclosed findings consistent with a microadenoma. Cushing’s disease was diagnosed, and the patient underwent transsphenoidal resection of the adenoma. He felt symptomatically better postoperatively but had similar complaints after 1 year. Repeated MRI showed a 7-mm pituitary adenoma on the left side. The patient underwent a second transsphenoidal adenomectomy. MRI after 6 months showed several 3-mm adenomas on the left and a 6-mm adenoma on the right side of the pituitary gland. The patient underwent a third operation at a different institution. Most patients with Cushing’s disease have a solitary corticotroph microadenoma but rarely may have diffuse corticotroph hyperplasia. Occurrence of multiple adenomas, as in our patient, is very uncommon, and in such cases, the therapeutic approach should be hypophysectomy rather than adenomectomy.
منابع مشابه
Molecular Biology of Cushing’s Disease
Abstract The proximal molecular pathogenesis of ACTH-secreting pituitary adenomas remains enigmatic. Several transgenic mice models have contributed important knowledge to understanding human pituitary disease; animal and cell models have provided novel insights into mechanisms underlying the pathogenesis of ACTH-secreting pituitary adenomas, mostly due to cell cycle disruption. Defective gluco...
متن کاملPituitary Disorders Medical Treatment of Cushing’s Disease with Pasireotide
Cushing’s disease is the most common form of endogenous Cushing’s syndrome and results from excess adrenocorticotropic hormone (ACTH) production by a corticotroph pituitary adenoma. Transsphenoidal surgical removal of the corticotroph adenoma is the treatment of choice for patients with Cushing’s disease. However, despite advances in surgery, complete tumour removal is sometimes impossible and ...
متن کاملUSP8 mutation in Cushing's disease
Pituitary corticotroph adenomas, also referred to as Cushing’s disease (CD), secret large amounts of adrenocorticotropic hormone (ACTH), resulting in excess glucocorticoids and hypercortisolism [1]. The diagnosis of hypercortisolism is complicate and sometimes difficult because its clinical features overlap with other common diseases. Currently, 65-90% of patients achieve complete or partial re...
متن کاملMolecular pathology shows p16 methylation in nonadenomatous pituitaries from patients with Cushing's disease.
PURPOSE The majority of cases of Cushing's disease are due to the presence of a corticotroph microadenoma. Less frequently no adenoma is found and histology shows either corticotroph hyperplasia, or apparently normal pituitary. In this study we have used molecular pathology to determine whether the tissue labeled histologically as "normal" is indeed abnormal. EXPERIMENTAL DESIGN Tissue from 3...
متن کاملPaediatric cyclical Cushing’s disease due to corticotroph cell hyperplasia
BACKGROUND Cushing's disease is very rare in the paediatric population. Although uncommon, corticotroph hyperplasia causing Cushing's syndrome has been described in the adult population, but appears to be extremely rare in children. Likewise, cyclical cortisol hypersecretion, while accounting for 15 % of adult cases of Cushing's disease, has only rarely been described in the paediatric populati...
متن کامل